Tevogen Bio Holdings (TVGN)

• Market cap: $63.9M
• 1 day: -5.9%
• 5 days: -16.62%
• 1 month: -14.35%
• 3 months: -51.53%
• 6 months: -71.3%
• Year to date: -17.95%
• 1 year: -79.41%
• 5 years: -97%
• 10 years: -97%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17